Alterity Therapeutics Limited (ASX:ATH)
Australia · Delayed Price · Currency is AUD 0.0110
+0.0010 (10.00%)
May 8, 2026, 4:10 PM AEST
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of 119.63 million as of May 8, 2026. Its market cap has increased by 63.83% in one year.
Market Cap
119.63M
Enterprise Value
70.53M
Revenue
6.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since March 28, 2000, Alterity Therapeutics's market cap has increased from 51.51M to 119.63M, an increase of 132.25%. That is a compound annual growth rate of 3.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 119.63M | 37.50% |
| Dec 31, 2025 | 87.00M | 104.41% |
| Dec 31, 2024 | 42.56M | 116.97% |
| Dec 29, 2023 | 19.62M | -18.82% |
| Dec 30, 2022 | 24.16M | -52.19% |
| Dec 31, 2021 | 50.54M | -19.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinogen Medical | 168.80M |
| Recce Pharmaceuticals | 144.59M |
| Nyrada | 135.95M |
| Dimerix | 129.09M |
| Island Pharmaceuticals | 104.31M |
| Arovella Therapeutics | 90.66M |
| Paradigm Biopharmaceuticals | 89.33M |
| Immutep | 88.42M |